Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment

Eric L. Ross, David W. Hutton, Joshua D. Stein, +3

JAMA Ophthalmology

Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States

Eric L. Ross, Kara Zivin, Daniel F. Maixner

JAMA Psychiatry

Prediction of Suicide Attempts Using Clinician Assessment, Patient Self-report, and Electronic Health Records

Matthew K. Nock, Alexander J. Millner, Eric L. Ross, +12

JAMA Network Open

Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples

Rochelle P. Walensky, Eric L. Ross, Nagalingeswaran Kumarasamy, +17

New England Journal of Medicine

Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US

Eric L. Ross, Marc S. Weinberg, Steven E. Arnold

JAMA Neurology

Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US

Eric L. Ross, Kelly L. Zuromski, Ben Y. Reis, +3

JAMA Psychiatry

The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy

Eric L. Ross, Milton C. Weinstein, Bruce R. Schackman, +5

Clinical Infectious Diseases

Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness

Yazdan Yazdanpanah, Julian Perelman, Madeline A. DiLorenzo, +13

PLoS ONE

The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States

Eric L. Ross, Sandeep Vijan, Erin M. Miller, +2

Annals of Internal Medicine

Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States

Eric L. Ross, Djøra I. Soeteman

Psychiatric Services